Literature DB >> 9685913

Enhanced transdermal delivery of AZT (Zidovudine) using iontophoresis and penetration enhancer.

S Y Oh1, S Y Jeong, T G Park, J H Lee.   

Abstract

The effect of current, its magnitude and penetration enhancers (propylene glycol/oleic acid) on the transdermal flux of AZT (Zidovudine) across hairless mouse skin was studied and the results were compared. The in vitro iontophoretic flux from AZT solution increased to about 5-40 fold that obtained by passive diffusion, depending on the magnitude of current density. When the donor side was karaya gum matrix, instead of solution, the flux enhancement effect by iontophoresis was much smaller. Incorporation of penetration enhancers into the matrix increased the passive flux 2-50 fold, depending on the amount of penetration enhancers in the matrix. These enhancers worked synergistically with iontophoresis in the transdermal transport: a much larger flux than that expected from a simple additive effect was observed. Electrical resistance data from our previous work is utilized to further discuss this synergistic effect.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9685913     DOI: 10.1016/s0168-3659(97)00162-4

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  13 in total

Review 1.  Synergistic effect of enhancers for transdermal drug delivery.

Authors:  S Mitragotri
Journal:  Pharm Res       Date:  2000-11       Impact factor: 4.200

2.  Magnetophoresis in combination with chemical enhancers for transdermal drug delivery.

Authors:  Srinivasa M Sammeta; Michael A Repka; S Narasimha Murthy
Journal:  Drug Dev Ind Pharm       Date:  2011-03-30       Impact factor: 3.225

3.  A novel transdermal delivery system for the anti-inflammatory lumiracoxib: influence of oleic acid on in vitro percutaneous absorption and in vivo potential cutaneous irritation.

Authors:  Tailane Sant'Anna Moreira; Valéria Pereira de Sousa; Maria Bernadete Riemma Pierre
Journal:  AAPS PharmSciTech       Date:  2010-04-07       Impact factor: 3.246

Review 4.  Current and emerging formulation strategies for the effective transdermal delivery of HIV inhibitors.

Authors:  Anthony S Ham; Robert W Buckheit
Journal:  Ther Deliv       Date:  2015-02

5.  Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.

Authors:  Akhmad Kharis Nugroho; Oscar Della Pasqua; Meindert Danhof; Joke A Bouwstra
Journal:  Pharm Res       Date:  2004-11       Impact factor: 4.200

6.  Studies on transdermal delivery enhancement of zidovudine.

Authors:  Evrim Atilay Takmaz; Ozge Inal; Tamer Baykara
Journal:  AAPS PharmSciTech       Date:  2009-01-16       Impact factor: 3.246

7.  Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCl concentration.

Authors:  Akhmad Kharis Nugroho; Gai Ling Li; Meindert Danhof; Joke A Bouwstra
Journal:  Pharm Res       Date:  2004-05       Impact factor: 4.200

8.  Effects of fatty acids and iontophoresis on the delivery of midodrine hydrochloride and the structure of human skin.

Authors:  Yiping Wang; Qiuxi Fan; Yifan Song; Bozena Michniak
Journal:  Pharm Res       Date:  2003-10       Impact factor: 4.200

9.  In vitro and ex vivo evaluations on transdermal delivery of the HIV inhibitor IQP-0410.

Authors:  Anthony S Ham; William Lustig; Lu Yang; Ashlee Boczar; Karen W Buckheit; Robert W Buckheit
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

10.  Enhancement of the transdermal delivery of zidovudine by pretreating the skin with two physical enhancers: microneedles and sonophoresis.

Authors:  Irene de Jesús Martínez-Segoviano; Adriana Ganem-Rondero
Journal:  Daru       Date:  2021-07-03       Impact factor: 4.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.